An Observational Follow-Up Study of Pediatric Patients Who Participated in a Previous Respiratory Syncytial Virus (RSV)-Induced Bronchiolitis Study of Montelukast

Phase 1

• Conditions: asthma and atopic diseases; MedDRA version: 9.1Level: LLTClassification code 10003560Term: Asthma NOS; MedDRA version: 9.1Level: LLTClassification code 10003637Term: Atopic

• Registration Number: EUCTR2007-003971-38-DE
• Lead Sponsor: Merck & Co., Inc.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-02-21
• Study Completion: 2011-10-28
• Last Update Posted: 30 March 2020

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

Patient successfully completed Visit 8 of Protocol 272.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patient has developed or has been diagnosed with any illness or congenital disorder
that could be immediately life threatening (e.g., arrhythmias congenital heart disease,
brittle diabetes,” neoplasia incompletely cured or treated within the last 3 months),
or would pose a restriction on participation or successful completion of the study.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified